... The highly qualified team develops and produces new targets for pharmaceuticals / diagnostics and offers a broad spectrum of research & development opportunities and services in genomics and proteomics for the biotechnology market.

Upcoming FP-7 calls could be addressed:
WP I Health
Development and production of new, high-affinity protein scaffolds for therapeutic use
- Development of multi-analyte diagnostic tests
- Development of tools to control microbial biofilms with relevance to clinical drug resistance.

WP II Agrofood Biotechnology
Optimised Animal Health

The company offers a technology platform for molecular-biology projects. Especially the transfer from DNA information level to proteins and monoclonal antibodies is a central part of the lab routine. The company has a long track with recombinant proteins in the field of cancer and
microbiological diseases, and is particularly interested in the development of new gene carrier methods (e.g. by the application of its targeted genetic conditioning technology) for in vitro and in vivo use.
The fields of use are:
-Pharma: new therapeutic entities (NTE), active pharmaceutical ingredients (API), pharmaceutical generics, active or passive vaccines,
-Diagnostics: cancer, immunology and infectious diseases, developing high quality assay
 components like recombinant proteins and polyclonal/monoclonal tailor-made antibodies

Development stage: Idea

European funding source(s): Health, Food, Agriculture and Biotechnology, FP7 - Co-operation

Type of Project: FP7 Collaborative Research, Joint Technology Initiative

Keywords: Medicine, Human Health (006001), Biology/Biotechnology (006002), Genome Research (006003), Gene Expression, Proteome Research (006003002), Diagnostics, Diagnosis (006001006), Gene - DNA Therapy (006001009), Pharmaceutical Products/Drugs (006001016), Virus, Virology/Antibiotics/Bacteriology (006001019), Genetic Engineering (006002004), In vitro Testing, Trials (006002005), Microbiology (006002006), Molecular design (006002007)

Organisation type: Company

Organisation size: <50

Other details: In general the company handles unique services for the genomics and proteomics in the Life Sciences Industry.

Target partner organisation type(s): SME (<250 employees), Large Company, University, Research/Technology Centre, Other

Target partner expertise sought: Organisations searching for alternate technologies to develop new pathways for new compounds and bio products in the life sciences industry. (Pharmaceutical, Diagnostics, Cosmetics)

Application domains : BIOLOGICAL SCIENCES, Medicine, health,
Biotechnology, Veterinary, Pharmaceutical/Comestics, Food - Agro Industry